Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Gemtuzumab (Mylotarg)

Also known as Cma-676, Mylotarg, Cdp-771, Way-Cma-676, Gemtuzumab Ozogamicin, Hp67.6-Calicheamicin, and Calicheamicin-Conjugated Humanized Anti-Cd33 Monoclonal Antibody

Gemtuzumab ozogamicin (marketed by Wyeth as Mylotarg) is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myelogenous leukemia from 2000-2010. It was withdrawn from market in June 2010 when a clinical trial showed the drug increased patient death and added no benefit over conventional cancer therapies.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed gemtuzumab to treat blastomycosis, rabies, west nile virus, and pick disease.

Ajax-loader Loading...